Episode Details

Australia’s drug regulator has issued a rare but serious warning about Ozempic, Mounjaro, and other diabetes/weight-loss drugs — linking them to a potentially blinding eye condition, non-arteritic anterior ischemic optic neuropathy — after reviewing 36 reported cases. Patients are urged to seek immediate medical help if they experience sudden vision loss, but doctors are advised not to stop prescriptions without consultation. While experts acknowledge the risk, they emphasize that the drugs’ benefits in preventing heart attacks, strokes, and kidney disease far outweigh this uncommon side effect. The TGA’s review, sparked by a 2024 study, led to updated safety warnings after consultation with medical experts. No cases were linked to Trulicity, and doctors continue to support these medications as life-saving tools — unless patients already have eye conditions.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/fadd6cfb43dc484d